Clinical trial · Observational
Serum Cholesterol and Gastric Neoplasm
Serum Cholesterol and Gastric Neoplasm: Nested Case-control Study
NCT02041312CI-TRIAL-00025024SCGNunknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Investigators have a plan to conduct nested case-control study to investigate the association between serum cholesterol levels including TC, HDL-C, LDL-C, triglyceride (TG), apolipoproteins and gastric neoplasm. In addition, further analyses were performed to evaluate the possible role of the serum cholesterol as a predictor for the differentiation and prognosis of gastric neoplasm.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Gastric Cancer | Malignant Gastric Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| No intervention | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Gastric cancer
- description
- No intervention
- interventionNames
- Other: No intervention
Primary outcomes (1)
- measure
- Cholesterol level in paitents with and withoutgastric neoplasm
- timeFrame
- up to 24 months
- description
- Serum cholesterol levels including TC, HDL-C, LDL-C, triglyceride (TG), apolipoproteins will be checked and compared in paitents with and withoutgastric neoplasm.
Secondary outcomes (1)
- measure
- Degree of decresed serum cholesterol levels in paitents with gastric neoplasm
- timeFrame
- up to 24 months
- description
- 1. Degree of decresed serum cholesterol levels including TC, HDL-C, LDL-C, triglyceride (TG), apolipoproteins in patients with gastric neoplasm compare to the patients without gastric neoplasm. 2. Degree of decresed serum cholesterol levels including TC, HDL-C, LDL-C, triglyceride (TG), apolipoproteins in patients with gastric neoplasm according to the stage of gastric neoplasm.
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * All subjects who visited the department of gastroenterology, surgery, or Healthcare Screening \& Promotion Center at Asan Medical Center and diagnosed as gastric cancer Exclusion Criteria: * Subjects who has history about drug for cholesterol, diabetes, liver disease, and/or thyroid disease. * Subjects who do not want to be enrolled this study
References
Publications (0)
Data not yet available
No reference posted for this study.